Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001082985 | SCV000262082 | benign | Alstrom syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000224703 | SCV000281153 | benign | not provided | 2015-06-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000418663 | SCV000529347 | benign | not specified | 2016-10-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Personalized Diabetes Medicine Program, |
RCV000445406 | SCV000536968 | benign | Monogenic diabetes | 2019-02-08 | criteria provided, single submitter | research | ACMG criteria: BP4 (REVEL score 0.017 + 5 predictors, not using PP3/4 predictors), BA1 (5.7% in gnomAD African), BS2 (46 homozygotes in gnomAD), BP1 (most ALMS1 pathogenic variants are truncating)= benign |
Laboratory for Molecular Medicine, |
RCV000418663 | SCV000966251 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | p.Thr1384Arg in exon 8 of ALMS1: This variant is not expected to have clinical s ignificance because it has been identified in 5.85% (573/9792) of African chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs115517108). |
Athena Diagnostics | RCV000224703 | SCV001143001 | benign | not provided | 2019-03-21 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV001082985 | SCV002605253 | benign | Alstrom syndrome | criteria provided, single submitter | research | Potent mutations in ALMS1 are associated with a rare condition called Alstrom syndrome. It can cause excessive eating, insulin resistance. However, no evidence is found to ascertain the role of rs115517108 in Alstrom syndrome yet. | |
Ambry Genetics | RCV002327067 | SCV002630245 | benign | Cardiovascular phenotype | 2019-01-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV001082985 | SCV004563987 | benign | Alstrom syndrome | 2023-09-06 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001082985 | SCV001458925 | benign | Alstrom syndrome | 2020-09-16 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000418663 | SCV002034245 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000224703 | SCV002035657 | likely benign | not provided | no assertion criteria provided | clinical testing |